NCT03583138View on ClinicalTrials.gov

HIV, Buprenorphine, and the Criminal Justice System (STRIDE2)

CompletedOBSERVATIONAL
Enrollment

159

Participants

Timeline

Start Date

June 23, 2014

Primary Completion Date

December 15, 2015

Study Completion Date

June 30, 2017

Conditions
Human Immunodeficiency VirusAcquired Immunodeficiency SyndromeOpiate AddictionDrug Dependence
Interventions
DRUG

buprenorphine

To provide buprenorphine for 12 months for those who are interested in receiving it.

Trial Locations (1)

20060

Howard University, Washington D.C.

All Listed Sponsors
collaborator

National Institute on Drug Abuse (NIDA)

NIH

collaborator

George Mason University

OTHER

collaborator

Howard University

OTHER

lead

Yale University

OTHER

NCT03583138 - HIV, Buprenorphine, and the Criminal Justice System (STRIDE2) | Biotech Hunter | Biotech Hunter